Neuronal intranuclear inclusion disease: Report on a case originally diagnosed as dopa-responsive dystonia with lewy bodies

Movement Disorders

Volumn 20, Issue 10, 2005, Pages 1345-1349

  Paviour, Dominic C ^a   Revesz, Tamas ^a   Holton, Janice L ^a   Evans, Andrew ^a   Olsson, Jan Edvin ^b   Lees, Andrew J ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Differential diagnosis; Juvenile parkinsonism; Neuronal intranuclear inclusion disease; Rectal biopsy

Indexed keywords

CARBAMAZEPINE; LEVODOPA; ORPHENADRINE;

ADULT; ARTICLE; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DYSTONIA; EOSINOPHIL; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; LEWY BODY; NERVE CELL; NEURONAL INTRANUCLEAR INCLUSION DISEASE; PARKINSONISM; PRIORITY JOURNAL; RECTUM BIOPSY;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; EOSINOPHILIA; FATAL OUTCOME; FEMALE; HUMANS; HYALIN; INTRANUCLEAR INCLUSION BODIES; LEWY BODY DISEASE; LUNG; NEURODEGENERATIVE DISEASES; NEURONS; RECTUM;

EID: 27844453944     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20559     Document Type: Article

References (48)

1. Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB. A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol (Berl) 1968;10:54-73.
2. Funata N, Maeda Y, Koike M, et al. Neuronal intranuclear hyaline inclusion disease: report of a case and review of the literature. Clin Neuropathol 1990;9:89-96.
3. Garen PD, Powers JM, Young GF, Lee V. Neuronal intranuclear hyaline inclusion disease in a nine year old. Acta Neuropathol (Berl) 1986;70:327-332.
4. Goutieres F, Mikol J, Aicardi J. Neuronal intranuclear inclusion disease in a child: diagnosis by rectal biopsy. Ann Neurol 1990; 27:103-106.
5. Haltia M, Tarkkanen A, Somer H, Palo J, Karli H. Neuronal intranuclear inclusion disease. Clinical ophthalmological features and ophthalmic pathology. Acta Ophthalmol (Copenh) 1986;64: 637-643.
6. Kimber TE, Blumbergs PC, Rice JP, et al. Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions. J Neurol Sci 1998;160:33-40.
7. Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Ann Neurol 1985;17:405-407.
8. Munoz-Garcia D, Ludwin SK. Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 1986;36:785-790.
9. Takahashi J, Fukuda T, Tanaka J, Minamitani M, Fujigasaki H, Uchihara T. Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol (Berl) 2000;99:589-594.
10. Sung JH, Ramirez-Lassepas M, Mastri AR, Larkin SM. An unusual degenerative disorder of neurons associated with a novel intranuclear hyaline inclusion (neuronal intranuclear hyaline inclusion disease). A clinicopathological study of a case. J Neuropathol Exp Neurol 1980;39:107-130.
11. Sloane AE, Becker LE, Ang LC, Wark J, Haslam RH Neuronal intranuclear hyaline inclusion disease with progressive cerebellar ataxia. Pediatr Neurol 1994;10:61-66.
12. Oyer CE, Cortez S, O'Shea P, Popovic M. Cardiomyopathy and myocyte intranuclear inclusions in Deuronal intranuclear inclusion disease: a case report. Hum Pathol 1991;22:722-724.
13. Patel H, Norman MG, Perry TL, Berry KE. Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a case and review of the literature. J Neurol Sci 1985;67:57-65.
14. Softer D. Neuronal intranuclear hyaline inclusion disease presenting as Friedreich's ataxia. Acta Neuropathol (Berl) 1985;65:322-329.
15. Michaud J, Gilbert JJ. Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a new case with light and electron microscopic studies. Acta Neuropathol (Berl) 1981;54: 113-119.
16. Malandrini A, Fabrizi GM, Cavallaro T, et al. Neuronal intranuclear inclusion disease: polymerase chain reaction and ultrastructural study of rectal biopsy specimen in a new case. Acta Neuropathol (Berl) 1996;91:215-218.
17. Parker JC Jr, Dyer ML, Paulsen WA. Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis. J Clin Neuroophthalmol 1987;7:244-249.
18. Schuffler MD, Bird TD, Sumi SM, Cook A. A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterology 1978;75:889-898.
19. Tateishi J, Nagara H, Ohta M, Matsumoto T, Fukunaga H, Shida K. Intranuclear inclusions in muscle, nervous tissue, and adrenal gland. Acta Neuropathol (Berl) 1984;63:24-32.
20. Weidenheim KM, Dickson DW. Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. Clin Neuropathol 1995;14:93-99.
21. Barnett JL, McDonnell WM, Appelman HD, Dobbins WO. Familial visceral neuropathy with neuronal intranuclear inclusions: diagnosis by rectal biopsy. Gastroenterology 1992;102:684-691.
22. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
23. O'Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ. Neuronal intranuclear inclusion disease and juvenile parkinsonism. Mov Disord 2000;15:990-995.
24. Takahashi-Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology 2003;23:351-359.
25. Gibb WR, Lees AJ. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988;38:1402-1406.
26. Lucking CB, Durr A, Bonifati V, et at. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
27. Paviour DC, Surtees RA, Lees AJ. Diagnostic considerations in juvenile parkinsonism. Mov Disord 2004;19:123-135.
28. Olsson JE, Brunk U, Lindvall B, Eeg-Olofsson O. Dopa-responsive dystonia with depigmentation of the substantia nigra and formation of Lewy bodies. J Neurol Sci 1992; 112:90 -95.
29. Waggener JD, Beggs J, Sidell AD. Virus like filaments in juvenile parkinsonism. J Neuropathol Exp Neurol 1978;31:187.
30. Bebin EM, Fryburg JS, Trugman JM. Dopa responsive dystonia (DRD) presenting in the first year of life. Neurology 1995; 45(Suppl):184.
31. Parker JC Jr, Dyer ML, Paulsen WA. Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis. J Clin Neuroophthalmol 1987;7:244-249.
32. Hwang WJ, Calne DB, Tsui JKC, Fuente-Fernandez R. The long-term response to levodopa in dopa-responsive dystonia. Parkinsonism Relat Disord 2001;8:1-5.
33. Nygaard TG. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993;60:577-585.
34. Rajput AH, Gibb WR, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994;35:396-402.
35. Grotzsch H, Pizzolato GP, Ghika J, et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002;58:1839-1842.
36. Furukawa Y, Kapatos G, Haycock JW, et al. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Ann Neurol 2002;51:637-641.
37. Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 2002;125:1760-1771.
38. Munoz E, Rey MJ, Mila M, et al. Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease. J Neurol Sci 2002;200:19-25.
39. Holmberg M, Duyckaerts C, Durr A, et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mot Genet 1998;7:913-918.
40. Gilman S, Sima AA, Junck L, et al. Spinocerebellar ataxia type I with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996;39:241-255.
41. Pang JT, Giund P, Chamberlain S, et al. Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases, Brain 2002;125:656-663.
42. Becher MW, Ross CA. Intranuclear neuronal inclusions in DR-PLA. Mov Disord 1998;13:852-853.
43. Becher MW, Kotzuk JA, Sharp AH et al. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 1998; 4:387-397.
44. Walker RH, Morgello S, Davidoff-Feldman B, et al. Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology 2002;58:1031-1037.
45. Lieberman AP, Trojanowski JQ Leonard DG, et al. Ataxin I and ataxin 3 in neuronal intranuclear inclusion disease. Ann Neurol 1999;46:271-273.
46. Trottier Y, Lutz Y, Stevanin G, et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995;378:403-406.
47. Lieberman AP, Robitaille Y, Trojanowski JQ Dickson DW, Fischbeck KH. Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet 1998;351:884.
48. Takahashi J, Tanaka J, Arai K, et al. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 2001;60:369-376.